首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Feline XLF accumulates at DNA damage sites in a Ku‐dependent manner
【2h】

Feline XLF accumulates at DNA damage sites in a Ku‐dependent manner

机译:猫XLF以Ku依赖性方式在DNA损伤位点积累

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Resistance to radiotherapy and chemotherapy is a common problem in the treatment of cancer in humans and companion animals, including cats. There is thus an urgent need to develop new treatments. Molecularly targeted therapies hold the promise of high specificity and significant cancer‐killing effects. Accumulating evidence shows that DNA double‐strand break (DSB) repair proteins, which function in Ku‐dependent non‐homologous DNA‐end joining (NHEJ), are potential target molecules for next‐generation cancer therapies. Although cancer radioresistance in cats has been previously described, there are no reports on feline Ku‐dependent NHEJ. Here, we cloned and sequenced feline XLF cDNA and characterized X‐ray repair cross‐complementing protein 4‐like factor (XLF), which is one of the core NHEJ proteins. We demonstrated that feline XLF localizes to the nuclei of feline cells and that feline XLF immediately accumulates at laser‐induced DSB sites in a Ku‐dependent manner. Amino acid sequence alignment analysis showed that feline XLF has only 80.9% identity with human XLF protein, while the predicted nuclear localization signal and putative 14‐3‐3‐binding motif are perfectly conserved among human, cat, dog, chimpanzee, and mouse. These findings are consistent with the hypothesis that regulation of subcellular localization is important for the function of XLF. Furthermore, these findings may be useful in clarifying the mechanisms underlying feline Ku‐dependent DSB repair and feline cell radioresistance, and possibly facilitate the development of new molecularly targeted therapies that target common proteins in human and feline cancers.
机译:在人类和伴侣动物(包括猫)的癌症治疗中,对放射疗法和化学疗法的抵抗力是一个普遍的问题。因此,迫切需要开发新的治疗方法。分子靶向疗法有望带来高特异性和显着的杀癌作用。越来越多的证据表明,在Ku依赖性非同源DNA末端连接(NHEJ)中起作用的DNA双链断裂(DSB)修复蛋白是下一代癌症治疗的潜在靶标分子。尽管先前已经描述过猫的放射线抗性,但尚无猫科动物依赖NHEJ的报道。在这里,我们克隆并测序了猫XLF cDNA,并对X射线修复交叉互补蛋白4样因子(XLF)进行了表征,这是NHEJ的核心蛋白之一。我们证明了猫XLF定位于猫细胞的细胞核,并且猫XLF立即以Ku依赖性方式聚集在激光诱导的DSB部位。氨基酸序列比对分析表明,猫XLF与人XLF蛋白仅具有80.9%的同一性,而预测的核定位信号和推定的14-3-3结合基序在人,猫,狗,黑猩猩和小鼠之间完全保守。这些发现与亚细胞定位的调节对于XLF的功能很重要的假设是一致的。此外,这些发现可能有助于阐明猫依赖KuB的DSB修复和猫细胞放射抗性的潜在机制,并可能促进针对人和猫癌中常见蛋白质的新型分子靶向疗法的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号